SlideShare a Scribd company logo
HEPATIC®
VERSION 1.6
A dedicated tool for HCV-
infected patient care &
treatment
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
ABL OFFERING OVERVIEW
Software for clinics (EMR, registry, data mining)
•HIV, HCV,
•HBV, HPV, TB
Software for laboratories (Sanger and NGS data analysis)
•HIV, HCV, HBV, CMV, TB , HSV
IT services (interface, integration, consolidation)
•Private labs, NHLS, GeneXpert MTB
•Billing systems for private insurances
Reagents for sequencing (Sanger and NGS,
•HIV, HCV
•TB, HBV, HPV
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
HEPATIC®
WHY ?
 New direct antiviral agents (DAAs)
 Interferon-free based Rx
 Promise of HCV cure
 Numerous clinical trials
 New Rx strategies will happen
 Large estimates of HCV-infected pts
 Few are diagnosed
 More is needed
 Patient status
 HCV testing
 Post-treatment and HCV cure assessment
 Progression or not to HCC and transplantation
 Are they specific risk factors?
 Several DAA treatment courses over the years
What ?
 Web-based platform
 Collaborative, multi-user, multi-site
 HCV-infected patients
 Data collection and analysis
 Routine & research
 Developed by ABL together
with the AEEH (Asociacion
Espanola para el Estudio del
Higado) (Spain)
 launched for research in November
2013
 http://aeeh.es/2011/10/hepatic/
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
HEPATIC® STRUCTURE (V1.6)
Any HCV + Patient
Demographics
Identification,
Gender, Residence
Geno/Subtype, IL28,
Death
Naïve, Pre-treated
Rx history
Cofactors
Liver
Non-liver
Visits
Standard
Vitals, Labs,
Procedures
Treatment
Type/Dosing, AEs
Outcome
HCC screening
Non invasive testing
Biopsy
Diagnosis
Treatment
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
HEPATIC® VERSION 1.6 Main & New features
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
DEMOGRAPHICS
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
PRE-TREATMENTS HISTORY
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
TREATMENTS
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
HCC SCREENING
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
MANAGEMENT OF THE SITE
Call with local
dial-in
Training
(Webcast)
Data hosting
Support
Remote
access
 Other technologies can be used
to manage the site
 Skype, Hangouts, Viber, WhatsApp
 VPN
 also regular phone 
 Team is speaking:
 English, French, German, Portuguese
and Spanish
 Support request is solved
usually in less than 2 business
days
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
THANK YOU!
Ronan Boulmé
ronan@ablsa.com
Matthieu Barralon
matthieu@ablsa.com
(C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY

More Related Content

PDF
Imminent release of HepatiC 1.8
PDF
Summary slide deck about HepatiC
PDF
March 192015talkforresidents final03232015 (1)
PPT
Hepatitis C and its Treatment
PPTX
Implementing a shared care model to prevent liver cancer and improve chronic ...
PDF
Sharing the Cure: Best Practices for Primary Care Providers to Improve HCV Pr...
PPTX
Khushi mawa on hep a b c d e and u..pptx
PPTX
DOC-20241213-WA0shhsjsnsjajbshs011..pptx
Imminent release of HepatiC 1.8
Summary slide deck about HepatiC
March 192015talkforresidents final03232015 (1)
Hepatitis C and its Treatment
Implementing a shared care model to prevent liver cancer and improve chronic ...
Sharing the Cure: Best Practices for Primary Care Providers to Improve HCV Pr...
Khushi mawa on hep a b c d e and u..pptx
DOC-20241213-WA0shhsjsnsjajbshs011..pptx

Similar to HepatiC(r) version 1.6 is released (20)

PDF
Hepatology2014
PPTX
Viral hepatitis A to E .
PPT
Hep b and c powerpoint final
PDF
Integrated Treatment for ARLD: Making it happen, 2 February 2017 Presentation...
PDF
Hepatology2014
PDF
Hepatology2014
PPTX
06 Acute and Chronic Viral Hepatitis.pptx
PDF
Understanding Hepatitis: Causes, Symptoms & Treatment Options
DOCX
Discover Effective Hepatitis Medicine for Better Health.docx
PPT
Masud.ppt.hbv
PDF
Hepatology2010 2nd edition
PDF
Hepatitis B & C - the Basics for Primary Care
PDF
Hepatitis coinfection
PPTX
Hepatitis c
PPTX
Hepatitis c
PDF
Chronic Liver Disease Conference 2015
PPTX
Revision of treatment protocols for hcv genotype 4 infection 2016
PPTX
Understanding Hepatitis: Causes, Symptoms & Treatment Options
PPT
Management del paziente in lista d'attesa per trapianto di fegato - Gastrolea...
PDF
Viral hepatitis by basit irshad
Hepatology2014
Viral hepatitis A to E .
Hep b and c powerpoint final
Integrated Treatment for ARLD: Making it happen, 2 February 2017 Presentation...
Hepatology2014
Hepatology2014
06 Acute and Chronic Viral Hepatitis.pptx
Understanding Hepatitis: Causes, Symptoms & Treatment Options
Discover Effective Hepatitis Medicine for Better Health.docx
Masud.ppt.hbv
Hepatology2010 2nd edition
Hepatitis B & C - the Basics for Primary Care
Hepatitis coinfection
Hepatitis c
Hepatitis c
Chronic Liver Disease Conference 2015
Revision of treatment protocols for hcv genotype 4 infection 2016
Understanding Hepatitis: Causes, Symptoms & Treatment Options
Management del paziente in lista d'attesa per trapianto di fegato - Gastrolea...
Viral hepatitis by basit irshad
Ad

Recently uploaded (20)

PPTX
Post Op complications in general surgery
PPTX
Morphology of Bacterial Cell for bsc sud
PPTX
vertigo topics for undergraduate ,mbbs/md/fcps
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPT
neurology Member of Royal College of Physicians (MRCP).ppt
PPTX
2 neonat neotnatology dr hussein neonatologist
PPTX
Neuropathic pain.ppt treatment managment
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
regulatory aspects for Bulk manufacturing
PPTX
obstructive neonatal jaundice.pptx yes it is
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
y4d nutrition and diet in pregnancy and postpartum
PPT
nephrology MRCP - Member of Royal College of Physicians ppt
PDF
Cardiology Pearls for Primary Care Providers
PPTX
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Acute Coronary Syndrome for Cardiology Conference
Post Op complications in general surgery
Morphology of Bacterial Cell for bsc sud
vertigo topics for undergraduate ,mbbs/md/fcps
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
focused on the development and application of glycoHILIC, pepHILIC, and comm...
MENTAL HEALTH - NOTES.ppt for nursing students
شيت_عطا_0000000000000000000000000000.pdf
neurology Member of Royal College of Physicians (MRCP).ppt
2 neonat neotnatology dr hussein neonatologist
Neuropathic pain.ppt treatment managment
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
regulatory aspects for Bulk manufacturing
obstructive neonatal jaundice.pptx yes it is
Copy of OB - Exam #2 Study Guide. pdf
y4d nutrition and diet in pregnancy and postpartum
nephrology MRCP - Member of Royal College of Physicians ppt
Cardiology Pearls for Primary Care Providers
PRESENTACION DE TRAUMA CRANEAL, CAUSAS, CONSEC, ETC.
preoerative assessment in anesthesia and critical care medicine
Acute Coronary Syndrome for Cardiology Conference
Ad

HepatiC(r) version 1.6 is released

  • 1. HEPATIC® VERSION 1.6 A dedicated tool for HCV- infected patient care & treatment (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 2. ABL OFFERING OVERVIEW Software for clinics (EMR, registry, data mining) •HIV, HCV, •HBV, HPV, TB Software for laboratories (Sanger and NGS data analysis) •HIV, HCV, HBV, CMV, TB , HSV IT services (interface, integration, consolidation) •Private labs, NHLS, GeneXpert MTB •Billing systems for private insurances Reagents for sequencing (Sanger and NGS, •HIV, HCV •TB, HBV, HPV (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 3. HEPATIC® WHY ?  New direct antiviral agents (DAAs)  Interferon-free based Rx  Promise of HCV cure  Numerous clinical trials  New Rx strategies will happen  Large estimates of HCV-infected pts  Few are diagnosed  More is needed  Patient status  HCV testing  Post-treatment and HCV cure assessment  Progression or not to HCC and transplantation  Are they specific risk factors?  Several DAA treatment courses over the years What ?  Web-based platform  Collaborative, multi-user, multi-site  HCV-infected patients  Data collection and analysis  Routine & research  Developed by ABL together with the AEEH (Asociacion Espanola para el Estudio del Higado) (Spain)  launched for research in November 2013  http://aeeh.es/2011/10/hepatic/ (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 4. HEPATIC® STRUCTURE (V1.6) Any HCV + Patient Demographics Identification, Gender, Residence Geno/Subtype, IL28, Death Naïve, Pre-treated Rx history Cofactors Liver Non-liver Visits Standard Vitals, Labs, Procedures Treatment Type/Dosing, AEs Outcome HCC screening Non invasive testing Biopsy Diagnosis Treatment (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 5. HEPATIC® VERSION 1.6 Main & New features (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 6. DEMOGRAPHICS (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 7. PRE-TREATMENTS HISTORY (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 8. TREATMENTS (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 9. HCC SCREENING (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 10. MANAGEMENT OF THE SITE Call with local dial-in Training (Webcast) Data hosting Support Remote access  Other technologies can be used to manage the site  Skype, Hangouts, Viber, WhatsApp  VPN  also regular phone   Team is speaking:  English, French, German, Portuguese and Spanish  Support request is solved usually in less than 2 business days (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY
  • 11. THANK YOU! Ronan Boulmé ronan@ablsa.com Matthieu Barralon matthieu@ablsa.com (C) ABL 2016 -- PROPRIETARY INFORMATION – PERSONAL AND LIMITED USE ONLY